Progressive Muscular Atrophy

Complex MONDO:0018687 Pathograph 2 Show in embeddings browser Motor Neuron Disease Neurodegenerative Disease

Progressive muscular atrophy (PMA) is a sporadic, adult-onset motor neuron disease clinically restricted to the lower motor neurons, presenting with slowly progressive flaccid weakness, muscle wasting, fasciculations, and reduced or absent tendon reflexes without clinical upper motor neuron signs. Degeneration of anterior horn and brainstem lower motor neurons drives skeletal muscle denervation. At autopsy PMA shares the TDP-43 proteinopathy of amyotrophic lateral sclerosis, and a substantial fraction of patients develop upper motor neuron signs over time, converting to clinically definite ALS; PMA is therefore regarded as a lower-motor-neuron-predominant variant within the ALS spectrum. It is a diagnosis of exclusion that must be distinguished from treatable lower motor neuron mimics, and generally carries longer survival than classic ALS.

Ask OpenScientist

Ask a research question about Progressive Muscular Atrophy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

4
Pathophys.
7
Phenotypes
2
Pathograph
3
Differentials
⚙

Pathophysiology

4
Lower Motor Neuron Degeneration
Progressive degeneration of lower motor neurons in the anterior (ventral) horn of the spinal cord and the brainstem motor nuclei produces denervation of skeletal muscle. Loss of these alpha motor neurons clinically manifests as flaccid weakness, muscle atrophy, fasciculations, and hyporeflexia or areflexia, with no clinical evidence of upper motor neuron involvement at presentation.
spinal cord motor neuron CL:0011001 motor neuron CL:0000100
motor neuron apoptotic process GO:0097049 ↑ INCREASED
anterior horn of the spinal cord UBERON:0002257 medulla oblongata (brainstem motor nuclei) UBERON:0001896
Downstream
Skeletal Muscle Denervation and Atrophy Loss of lower motor neurons denervates skeletal muscle, producing weakness and wasting.
Show evidence (2 references)
PMID:19917992 SUPPORT Human Clinical
"Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
Large clinical cohort defines PMA as a lower-motor-neuron syndrome, establishing lower motor neuron dysfunction as the defining pathophysiology.
PMID:21225272 SUPPORT Human Clinical
"All patients showed significant TDP-43 linked degeneration of LMNs"
Autopsy series of isolated lower-motor-neuron disease and PMA confirms degeneration of lower motor neurons.
TDP-43 Proteinopathy
Despite clinical restriction to the lower motor neuron, PMA shares the molecular neuropathology of ALS: widespread neuronal and glial accumulation of pathological, cytoplasmic 43 kDa transactive response DNA-binding protein (TDP-43) inclusions across the central nervous system. TDP-43 is an RNA-binding protein, and its nuclear depletion and cytoplasmic aggregation disrupt RNA processing in vulnerable motor neurons. This places PMA, isolated lower-motor-neuron disease, ALS, and FTLD-TDP on a single TDP-43 proteinopathy continuum. A minority of slowly progressive lower-motor-neuron-predominant cases lack TDP-43 inclusions at autopsy, indicating molecular heterogeneity within the clinical syndrome.
motor neuron CL:0000100
TARDBP hgnc:11571
TDP-43 inclusion body assembly GO:0070841 ↑ INCREASED RNA processing GO:0006397 ⚠ ABNORMAL
Show evidence (3 references)
PMID:21225272 SUPPORT Human Clinical
"MND limited to the LMN and PMA is part of a disease continuum that includes ALS and FTLD-TDP, all of which are characterized by widespread TDP-43 pathology"
Neuropathological study demonstrates that PMA carries the same widespread TDP-43 proteinopathy as ALS, placing it on a shared disease continuum.
PMID:21225272 SUPPORT Human Clinical
"we suggest that the next revision of the El Escorial criteria for the diagnosis of ALS include MND patients with disease clinically limited to the LMN and PMA as variants of ALS, which like classical ALS, are TDP-43 proteinopathies"
Authors classify PMA as a TDP-43 proteinopathy variant of ALS based on the autopsy distribution of TDP-43 pathology.
PMID:30511354 PARTIAL Human Clinical
"there may be a sporadic ALS subgroup that progresses slowly and shows no accumulation of phosphorylated TDP-43"
Clinicopathological report documents TDP-43-negative slowly progressive lower-motor-neuron-predominant ALS, qualifying the universality of TDP-43 proteinopathy in the PMA phenotype.
Phenotypic Conversion to ALS Spectrum
PMA is not a fixed entity but the lower-motor-neuron-predominant pole of the ALS spectrum. A substantial proportion of patients clinically diagnosed with PMA develop upper motor neuron signs during follow-up and convert to clinically definite ALS, and upper motor neuron pathology is frequently demonstrable at autopsy even when clinical signs are absent. This continuum has direct clinical and trial-design consequences, and motivates classifying PMA as a form of ALS rather than a distinct disease.
motor neuron CL:0000100
Show evidence (3 references)
PMID:19917992 SUPPORT Human Clinical
"Upper motor neuron (UMN) signs developed in 22% of patients with PMA within 61 months after diagnosis."
Cohort quantifies clinical conversion: 22% of PMA patients develop upper motor neuron signs within ~5 years, demonstrating progression along the ALS spectrum.
PMID:19917992 SUPPORT Human Clinical
"PMA is relentlessly progressive, and UMN involvement can occur, as also reported in imaging and postmortem studies. For these reasons, PMA should be considered a form of ALS."
Authors conclude that occult and clinical upper motor neuron involvement justifies classifying PMA as a form of ALS.
PMID:30511354 SUPPORT Human Clinical
"clinically appeared to only affect the lower motor neurons; however, upper motor neuron degeneration was detected at autopsy"
Long-course case with purely clinical lower-motor-neuron presentation shows subclinical upper motor neuron degeneration at autopsy, supporting occult ALS-spectrum pathology.
Skeletal Muscle Denervation and Atrophy
Loss of lower motor neurons removes trophic and contractile innervation of skeletal muscle fibers, producing chronic neurogenic atrophy. Clinically this manifests as relentlessly progressive flaccid weakness and wasting, often beginning asymmetrically and distally, accompanied by fasciculations and cramps, with electrophysiological evidence of denervation. Progressive respiratory muscle involvement (declining vital capacity) is the principal determinant of survival.
motor neuron apoptotic process GO:0097049 ↑ INCREASED
Show evidence (2 references)
PMID:17420313 SUPPORT Human Clinical
"Significant decline of muscle strength"
Prospective inception cohort documents progressive loss of muscle strength, reflecting ongoing denervation and neurogenic atrophy.
PMID:17420313 SUPPORT Human Clinical
"Vital capacity (VC) at baseline and decrease of VC during the first 6 months were significantly associated with outcome."
Respiratory muscle denervation, indexed by vital capacity, predicts survival, linking the denervation cascade to clinical outcome.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Progressive Muscular Atrophy Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

7
Digestive 1
Dysphagia OCCASIONAL Dysphagia HP:0002015
Show evidence (1 reference)
PMID:19917992 SUPPORT Human Clinical
"Noninvasive ventilation and gastrostomy were used frequently in PMA."
Frequent gastrostomy use reflects bulbar dysfunction with dysphagia and aspiration risk in advanced PMA.
Musculoskeletal 2
Muscle Weakness OBLIGATE Muscle weakness HP:0001324
Course: PROGRESSIVE
Show evidence (2 references)
PMID:19917992 SUPPORT Human Clinical
"Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
PMA is clinically defined by lower motor neuron dysfunction, of which weakness is the cardinal sign.
PMID:17420313 SUPPORT Human Clinical
"Significant decline of muscle strength"
Cohort documents progressive decline in muscle strength over follow-up.
Skeletal Muscle Atrophy VERY_FREQUENT Skeletal muscle atrophy HP:0003202
Show evidence (2 references)
PMID:17420313 SUPPORT Human Clinical
"the natural history and prognostic factors in patients with nonhereditary, adult-onset progressive muscular atrophy"
Progressive muscular atrophy is defined by progressive neurogenic muscle wasting, the cardinal feature of this phenotype.
PMID:19917992 SUPPORT Human Clinical
"Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
Muscle atrophy reflects the lower motor neuron dysfunction that clinically characterizes PMA.
Nervous System 2
Fasciculations FREQUENT Fasciculations HP:0002380
Show evidence (1 reference)
PMID:19917992 SUPPORT Human Clinical
"Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
Fasciculations are a characteristic lower motor neuron sign of the PMA syndrome described in this cohort.
Areflexia FREQUENT Areflexia HP:0001284
Show evidence (1 reference)
PMID:19917992 SUPPORT Human Clinical
"Demographic and other clinical variables did not differ at diagnosis between those who did or did not develop UMN signs."
PMA is defined by lower motor neuron signs without upper motor neuron signs at diagnosis; reduced or absent reflexes reflect this isolated LMN involvement.
Other 2
Motor Neuron Atrophy VERY_FREQUENT Motor neuron atrophy HP:0007373
Show evidence (1 reference)
PMID:21225272 SUPPORT Human Clinical
"All patients showed significant TDP-43 linked degeneration of LMNs"
Autopsy confirms degeneration of lower motor neurons in PMA.
EMG Neuropathic Changes FREQUENT EMG: neuropathic changes HP:0003445
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Progressive Muscular Atrophy:

Amyotrophic Lateral Sclerosis MONDO:0004976
Overlapping Features Classic ALS combines clinical upper and lower motor neuron signs; PMA lacks clinical upper motor neuron signs but lies on the same TDP-43 spectrum and may convert to ALS.
Distinguishing Features
  • PMA lacks clinical upper motor neuron signs (spasticity, hyperreflexia, Babinski) at presentation.
  • A proportion of PMA patients develop upper motor neuron signs and convert to clinically definite ALS over time.
  • PMA generally carries longer survival than classic ALS.
Show evidence (1 reference)
PMID:19917992 SUPPORT Human Clinical
"In PMA, patients were more likely to be male (p < 0.001), older (p = 0.007), and lived longer (p = 0.01) than in ALS."
Direct cohort comparison documents longer survival and demographic differences distinguishing PMA from ALS.
Multifocal Motor Neuropathy Not Yet Curated MONDO:0018979
Overlapping Features A treatable, immune-mediated pure motor neuropathy that mimics lower motor neuron disease and must be excluded before diagnosing PMA.
Distinguishing Features
  • Multifocal motor conduction block on nerve conduction studies (absent in PMA).
  • Frequently elevated anti-GM1 IgM antibodies.
  • Responds to immunotherapy (e.g., cyclophosphamide, IVIG), unlike PMA.
Show evidence (2 references)
PMID:2843079 SUPPORT Human Clinical
"Both patients were initially diagnosed as having lower motor neuron forms of amyotrophic lateral sclerosis."
Patients with treatable multifocal motor neuropathy were initially misdiagnosed as lower motor neuron motor neuron disease, illustrating why MMN must be excluded before diagnosing PMA.
PMID:2843079 SUPPORT Human Clinical
"Treatment with cyclophosphamide, however, was followed by marked improvement in strength in both patients."
The treatability of MMN underscores the clinical importance of distinguishing it from PMA.
Spinal Muscular Atrophy MONDO:0001516
Overlapping Features A hereditary lower motor neuron disorder (commonly SMN1-related) presenting with anterior horn cell loss; PMA is sporadic and adult-onset.
Distinguishing Features
  • SMA is hereditary (typically autosomal recessive SMN1 deletion); PMA is sporadic.
  • SMA usually has earlier (often childhood) onset, whereas PMA is an adult-onset disease.
Show evidence (1 reference)
PMID:17420313 SUPPORT Human Clinical
"To investigate the natural history and prognostic factors in patients with nonhereditary, adult-onset progressive muscular atrophy."
PMA is explicitly defined as nonhereditary and adult-onset, distinguishing it from hereditary, typically earlier-onset spinal muscular atrophy.
{ }

Source YAML

click to show 
name: Progressive Muscular Atrophy
creation_date: "2026-06-26T00:00:00Z"
category: Complex
description: >
  Progressive muscular atrophy (PMA) is a sporadic, adult-onset motor neuron disease
  clinically restricted to the lower motor neurons, presenting with slowly progressive
  flaccid weakness, muscle wasting, fasciculations, and reduced or absent tendon reflexes
  without clinical upper motor neuron signs. Degeneration of anterior horn and brainstem
  lower motor neurons drives skeletal muscle denervation. At autopsy PMA shares the
  TDP-43 proteinopathy of amyotrophic lateral sclerosis, and a substantial fraction of
  patients develop upper motor neuron signs over time, converting to clinically definite
  ALS; PMA is therefore regarded as a lower-motor-neuron-predominant variant within the
  ALS spectrum. It is a diagnosis of exclusion that must be distinguished from treatable
  lower motor neuron mimics, and generally carries longer survival than classic ALS.
disease_term:
  preferred_term: progressive muscular atrophy
  term:
    id: MONDO:0018687
    label: progressive muscular atrophy
parents:
- Motor Neuron Disease
- Neurodegenerative Disease
pathophysiology:
- name: Lower Motor Neuron Degeneration
  description: >
    Progressive degeneration of lower motor neurons in the anterior (ventral) horn of the
    spinal cord and the brainstem motor nuclei produces denervation of skeletal muscle.
    Loss of these alpha motor neurons clinically manifests as flaccid weakness, muscle
    atrophy, fasciculations, and hyporeflexia or areflexia, with no clinical evidence of
    upper motor neuron involvement at presentation.
  cell_types:
  - preferred_term: spinal cord motor neuron
    term:
      id: CL:0011001
      label: spinal cord motor neuron
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  locations:
  - preferred_term: anterior horn of the spinal cord
    term:
      id: UBERON:0002257
      label: ventral horn of spinal cord
  - preferred_term: medulla oblongata (brainstem motor nuclei)
    term:
      id: UBERON:0001896
      label: medulla oblongata
  biological_processes:
  - preferred_term: motor neuron apoptotic process
    term:
      id: GO:0097049
      label: motor neuron apoptotic process
    modifier: INCREASED
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
    explanation: >
      Large clinical cohort defines PMA as a lower-motor-neuron syndrome, establishing
      lower motor neuron dysfunction as the defining pathophysiology.
  - reference: PMID:21225272
    reference_title: "Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients showed significant TDP-43 linked degeneration of LMNs"
    explanation: >
      Autopsy series of isolated lower-motor-neuron disease and PMA confirms degeneration
      of lower motor neurons.
  downstream:
  - target: Skeletal Muscle Denervation and Atrophy
    description: Loss of lower motor neurons denervates skeletal muscle, producing weakness and wasting.
    evidence:
    - reference: PMID:21225272
      reference_title: "Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All patients showed significant TDP-43 linked degeneration of LMNs"
      explanation: Lower motor neuron loss is the proximate cause of downstream muscle denervation.
- name: TDP-43 Proteinopathy
  description: >
    Despite clinical restriction to the lower motor neuron, PMA shares the molecular
    neuropathology of ALS: widespread neuronal and glial accumulation of pathological,
    cytoplasmic 43 kDa transactive response DNA-binding protein (TDP-43) inclusions
    across the central nervous system. TDP-43 is an RNA-binding protein, and its nuclear
    depletion and cytoplasmic aggregation disrupt RNA processing in vulnerable motor
    neurons. This places PMA, isolated lower-motor-neuron disease, ALS, and FTLD-TDP on a
    single TDP-43 proteinopathy continuum. A minority of slowly progressive
    lower-motor-neuron-predominant cases lack TDP-43 inclusions at autopsy, indicating
    molecular heterogeneity within the clinical syndrome.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  genes:
  - preferred_term: TARDBP
    term:
      id: hgnc:11571
      label: TARDBP
  biological_processes:
  - preferred_term: TDP-43 inclusion body assembly
    term:
      id: GO:0070841
      label: inclusion body assembly
    modifier: INCREASED
  - preferred_term: RNA processing
    term:
      id: GO:0006397
      label: mRNA processing
    modifier: ABNORMAL
  evidence:
  - reference: PMID:21225272
    reference_title: "Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "MND limited to the LMN and PMA is part of a disease continuum that includes ALS and FTLD-TDP, all of which are characterized by widespread TDP-43 pathology"
    explanation: >
      Neuropathological study demonstrates that PMA carries the same widespread TDP-43
      proteinopathy as ALS, placing it on a shared disease continuum.
  - reference: PMID:21225272
    reference_title: "Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we suggest that the next revision of the El Escorial criteria for the diagnosis of ALS include MND patients with disease clinically limited to the LMN and PMA as variants of ALS, which like classical ALS, are TDP-43 proteinopathies"
    explanation: >
      Authors classify PMA as a TDP-43 proteinopathy variant of ALS based on the
      autopsy distribution of TDP-43 pathology.
  - reference: PMID:30511354
    reference_title: "Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "there may be a sporadic ALS subgroup that progresses slowly and shows no accumulation of phosphorylated TDP-43"
    explanation: >
      Clinicopathological report documents TDP-43-negative slowly progressive
      lower-motor-neuron-predominant ALS, qualifying the universality of TDP-43
      proteinopathy in the PMA phenotype.
- name: Phenotypic Conversion to ALS Spectrum
  description: >
    PMA is not a fixed entity but the lower-motor-neuron-predominant pole of the ALS
    spectrum. A substantial proportion of patients clinically diagnosed with PMA develop
    upper motor neuron signs during follow-up and convert to clinically definite ALS, and
    upper motor neuron pathology is frequently demonstrable at autopsy even when clinical
    signs are absent. This continuum has direct clinical and trial-design consequences,
    and motivates classifying PMA as a form of ALS rather than a distinct disease.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Upper motor neuron (UMN) signs developed in 22% of patients with PMA within 61 months after diagnosis."
    explanation: >
      Cohort quantifies clinical conversion: 22% of PMA patients develop upper motor
      neuron signs within ~5 years, demonstrating progression along the ALS spectrum.
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "PMA is relentlessly progressive, and UMN involvement can occur, as also reported in imaging and postmortem studies. For these reasons, PMA should be considered a form of ALS."
    explanation: >
      Authors conclude that occult and clinical upper motor neuron involvement justifies
      classifying PMA as a form of ALS.
  - reference: PMID:30511354
    reference_title: "Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "clinically appeared to only affect the lower motor neurons; however, upper motor neuron degeneration was detected at autopsy"
    explanation: >
      Long-course case with purely clinical lower-motor-neuron presentation shows
      subclinical upper motor neuron degeneration at autopsy, supporting occult ALS-spectrum
      pathology.
- name: Skeletal Muscle Denervation and Atrophy
  description: >
    Loss of lower motor neurons removes trophic and contractile innervation of skeletal
    muscle fibers, producing chronic neurogenic atrophy. Clinically this manifests as
    relentlessly progressive flaccid weakness and wasting, often beginning asymmetrically
    and distally, accompanied by fasciculations and cramps, with electrophysiological
    evidence of denervation. Progressive respiratory muscle involvement (declining vital
    capacity) is the principal determinant of survival.
  biological_processes:
  - preferred_term: motor neuron apoptotic process
    term:
      id: GO:0097049
      label: motor neuron apoptotic process
    modifier: INCREASED
  evidence:
  - reference: PMID:17420313
    reference_title: "Disease course and prognostic factors of progressive muscular atrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Significant decline of muscle strength"
    explanation: >
      Prospective inception cohort documents progressive loss of muscle strength,
      reflecting ongoing denervation and neurogenic atrophy.
  - reference: PMID:17420313
    reference_title: "Disease course and prognostic factors of progressive muscular atrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Vital capacity (VC) at baseline and decrease of VC during the first 6 months were significantly associated with outcome."
    explanation: >
      Respiratory muscle denervation, indexed by vital capacity, predicts survival,
      linking the denervation cascade to clinical outcome.
phenotypes:
- name: Muscle Weakness
  category: Neuromuscular
  frequency: OBLIGATE
  diagnostic: true
  description: Progressive flaccid weakness from lower motor neuron loss, often beginning asymmetrically and distally.
  phenotype_term:
    preferred_term: Muscle weakness
    term:
      id: HP:0001324
      label: Muscle weakness
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
    explanation: PMA is clinically defined by lower motor neuron dysfunction, of which weakness is the cardinal sign.
  - reference: PMID:17420313
    reference_title: "Disease course and prognostic factors of progressive muscular atrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Significant decline of muscle strength"
    explanation: Cohort documents progressive decline in muscle strength over follow-up.
- name: Skeletal Muscle Atrophy
  category: Neuromuscular
  frequency: VERY_FREQUENT
  diagnostic: true
  description: Neurogenic wasting of skeletal muscle secondary to chronic denervation.
  phenotype_term:
    preferred_term: Skeletal muscle atrophy
    term:
      id: HP:0003202
      label: Skeletal muscle atrophy
  evidence:
  - reference: PMID:17420313
    reference_title: "Disease course and prognostic factors of progressive muscular atrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the natural history and prognostic factors in patients with nonhereditary, adult-onset progressive muscular atrophy"
    explanation: Progressive muscular atrophy is defined by progressive neurogenic muscle wasting, the cardinal feature of this phenotype.
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
    explanation: Muscle atrophy reflects the lower motor neuron dysfunction that clinically characterizes PMA.
- name: Fasciculations
  category: Neuromuscular
  frequency: FREQUENT
  diagnostic: true
  description: Visible spontaneous motor unit discharges arising from degenerating lower motor neurons.
  phenotype_term:
    preferred_term: Fasciculations
    term:
      id: HP:0002380
      label: Fasciculations
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis (ALS)."
    explanation: Fasciculations are a characteristic lower motor neuron sign of the PMA syndrome described in this cohort.
- name: Areflexia
  category: Neurological
  frequency: FREQUENT
  description: Reduced or absent tendon reflexes consistent with isolated lower motor neuron involvement and absence of upper motor neuron signs.
  phenotype_term:
    preferred_term: Areflexia
    term:
      id: HP:0001284
      label: Areflexia
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Demographic and other clinical variables did not differ at diagnosis between those who did or did not develop UMN signs."
    explanation: >
      PMA is defined by lower motor neuron signs without upper motor neuron signs at
      diagnosis; reduced or absent reflexes reflect this isolated LMN involvement.
- name: Motor Neuron Atrophy
  category: Neurological
  frequency: VERY_FREQUENT
  description: Degeneration and loss of lower motor neurons in the anterior horn and brainstem motor nuclei.
  phenotype_term:
    preferred_term: Motor neuron atrophy
    term:
      id: HP:0007373
      label: Motor neuron atrophy
  evidence:
  - reference: PMID:21225272
    reference_title: "Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients showed significant TDP-43 linked degeneration of LMNs"
    explanation: Autopsy confirms degeneration of lower motor neurons in PMA.
- name: EMG Neuropathic Changes
  category: Neurological
  frequency: FREQUENT
  diagnostic: true
  description: Electromyographic evidence of chronic and active denervation reflecting lower motor neuron loss.
  phenotype_term:
    preferred_term: EMG neurogenic changes
    term:
      id: HP:0003445
      label: 'EMG: neuropathic changes'
- name: Dysphagia
  category: Neuromuscular
  frequency: OCCASIONAL
  description: Swallowing difficulty from bulbar (brainstem) lower motor neuron involvement in advanced disease.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Noninvasive ventilation and gastrostomy were used frequently in PMA."
    explanation: >
      Frequent gastrostomy use reflects bulbar dysfunction with dysphagia and aspiration
      risk in advanced PMA.
differential_diagnoses:
- name: Amyotrophic Lateral Sclerosis
  disease_term:
    preferred_term: amyotrophic lateral sclerosis
    term:
      id: MONDO:0004976
      label: amyotrophic lateral sclerosis
  description: Classic ALS combines clinical upper and lower motor neuron signs; PMA lacks clinical upper motor neuron signs but lies on the same TDP-43 spectrum and may convert to ALS.
  distinguishing_features:
  - PMA lacks clinical upper motor neuron signs (spasticity, hyperreflexia, Babinski) at presentation.
  - A proportion of PMA patients develop upper motor neuron signs and convert to clinically definite ALS over time.
  - PMA generally carries longer survival than classic ALS.
  evidence:
  - reference: PMID:19917992
    reference_title: "Study of 962 patients indicates progressive muscular atrophy is a form of ALS."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In PMA, patients were more likely to be male (p < 0.001), older (p = 0.007), and lived longer (p = 0.01) than in ALS."
    explanation: Direct cohort comparison documents longer survival and demographic differences distinguishing PMA from ALS.
- name: Multifocal Motor Neuropathy
  disease_term:
    preferred_term: multifocal motor neuropathy
    term:
      id: MONDO:0018979
      label: multifocal motor neuropathy
  description: A treatable, immune-mediated pure motor neuropathy that mimics lower motor neuron disease and must be excluded before diagnosing PMA.
  distinguishing_features:
  - Multifocal motor conduction block on nerve conduction studies (absent in PMA).
  - Frequently elevated anti-GM1 IgM antibodies.
  - Responds to immunotherapy (e.g., cyclophosphamide, IVIG), unlike PMA.
  evidence:
  - reference: PMID:2843079
    reference_title: "A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both patients were initially diagnosed as having lower motor neuron forms of amyotrophic lateral sclerosis."
    explanation: >
      Patients with treatable multifocal motor neuropathy were initially misdiagnosed as
      lower motor neuron motor neuron disease, illustrating why MMN must be excluded
      before diagnosing PMA.
  - reference: PMID:2843079
    reference_title: "A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Treatment with cyclophosphamide, however, was followed by marked improvement in strength in both patients."
    explanation: The treatability of MMN underscores the clinical importance of distinguishing it from PMA.
- name: Spinal Muscular Atrophy
  disease_term:
    preferred_term: spinal muscular atrophy
    term:
      id: MONDO:0001516
      label: spinal muscular atrophy
  description: A hereditary lower motor neuron disorder (commonly SMN1-related) presenting with anterior horn cell loss; PMA is sporadic and adult-onset.
  distinguishing_features:
  - SMA is hereditary (typically autosomal recessive SMN1 deletion); PMA is sporadic.
  - SMA usually has earlier (often childhood) onset, whereas PMA is an adult-onset disease.
  evidence:
  - reference: PMID:17420313
    reference_title: "Disease course and prognostic factors of progressive muscular atrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To investigate the natural history and prognostic factors in patients with nonhereditary, adult-onset progressive muscular atrophy."
    explanation: >-
      PMA is explicitly defined as nonhereditary and adult-onset, distinguishing it from
      hereditary, typically earlier-onset spinal muscular atrophy.